These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11879626)

  • 1. [Positron emission tomography (PET) in clinical oncology. Part II].
    Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
    Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT in oncology: for which tumours is it the reference standard?
    Collins CD
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1087-92. PubMed ID: 15052206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
    Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
    Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of positron emission tomography in oncology.
    Bomanji JB; Costa DC; Ell PJ
    Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
    Barghouth G; Allaoua M; Goerres GW
    Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography for benign and malignant disease.
    Visioni A; Kim J
    Surg Clin North Am; 2011 Feb; 91(1):249-66. PubMed ID: 21184913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
    Yang ZY; Hu SL; Shi W; Zhu BL; Xu JY; Zhang YJ
    Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron-emission tomography in oncology].
    Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
    Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
    Delbeke D
    J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
    Bar-Shalom R
    Radiol Clin North Am; 2007 Jul; 45(4):677-88, vi-vii. PubMed ID: 17706532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where can FDG-PET contribute most to anatomical imaging problems?
    Bingham JB
    Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
    Scott WJ; Schwabe JL; Gupta NC; Dewan NA; Reeb SD; Sugimoto JT
    Ann Thorac Surg; 1994 Sep; 58(3):698-703. PubMed ID: 7944691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography scanning is coming to a hospital near you soon!
    Bashir H; Shabo G; Nunan TO
    Clin Med (Lond); 2008 Apr; 8(2):134-9. PubMed ID: 18478853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
    Flanagan FL; Dehdashti F; Ogunbiyi OA; Kodner IJ; Siegel BA
    Ann Surg; 1998 Mar; 227(3):319-23. PubMed ID: 9527052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography imaging in melanoma and lymphoma.
    Abella-Columna E; Valk PE
    Semin Roentgenol; 2002 Apr; 37(2):129-39. PubMed ID: 12134366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.